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Matrix metalloproteinases (MMPs) are secretory endopeptidases. They have been associated with invasion by cancer-cell and metastasis.
Previous studies have demonstrated that proteolytic activity could be detected using fluorescence resonance energy transfer (FRET) with mutants
of GFP. To monitor MMP activity, we constructed vectors that encoded a MMP Substrate Site (MSS) between YFP and CFP. In vitro, YFP–
MSS–CFP can be used to detect MMP activity and 1,10-phenathroline inhibition of MMP activity. In living cells, MMPs are secreted proteins and
act outside of the cell, and therefore YFP–MSS–CFPdisplay was anchored on the cellular surface to detect extracellular MMP. A pDisplay-YC
vector expressing the YFP–MSS–CFPdisplay on the cellular surface was transfected into MCF-7 cells that expressed low levels of MMP. Efficient
transfer of energy from excited CFP to YFP within the YFP–MSS–CFPdisplay molecule was observed, and real-time FRET was declined when
MCF-7 was incubated with MMP2. However, no such transfer of energy was detected in the YFP–MSS–CFPdisplay expressing MDA-MB 435s
cells, in which high secretory MMP2 were expressed. The FRET sensor YFP–MSS–CFPdisplay can sensitively and reliably monitor MMP
activation in living cells and can be used for high-throughput screening of MMP inhibitors for anti-cancer treatments.
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Proteases are necessary for the normal biological function of
mammalian cells and have been associated with many
pathological processes, such as wound healing, inflammation,
and tumour invasion. Matrix metalloproteinases (MMPs) are a
family of secretory endopeptidases with hydrolytic activity for a
diverse spectrum of extracellular proteins [1,2]. Degradation of
the extracellular matrix (ECM) by MMPs aids tumour invasion
[2,3]. 72 kDa MMP2 (gelatinase A) and 92 kDa MMP9
(gelatinase B) are the two MMPs most closely correlated withAbbreviations: MMP, Matrix metalloproteinase; FRET, fluorescence
resonance energy transfer; ECFP, enhanced cyan fluorescence protein; EYFP,
enhanced yellow fluorescence protein; MSS, MMP Substrate Site; PDGFR,
platelet derived growth factor receptor
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particularly important, since they cleave collagen, the main
component of basement membranes [4,5]. Several MMPs are
expressed at much higher levels in cancerous tissue than in
normal tissue, and the extent of expression has been shown to
relate to tumour stage, invasiveness, metastasis and angiogen-
esis [1,6,19]. Many MMP inhibitors have been designed to treat
malignancies and other diseases associated with pathologic
angiogenesis, including several currently in clinical develop-
ment for cancer therapy, such as BB-2516, AG3340, COL-3,
AE941 [1].
To study MMP activity, methods have been developed for
measuring proteinase activity in vitro and in cultured cells. One
of the earliest developed methods, zymography, has been used
extensively; however, this method is not able to test MMP in
vivo. More recently, a near-infrared fluorescence sensor that can
measure enzymatic activities and provide an image of where
MMP-2 is located in vivo has been designed [8,9], and this
Fig. 1. Schematic representation of FP-FRET sensors for detecting MMP
activity. (A) Above: the 6His-tagged YFP–MSS–CFP expressed by plasmid
pET-28a-YC in E. coli. A twelve-amino-acid peptide LEGGIPVSLRSG linker
includes the MMP substrate site (MSS) sequence. The MMP substrate site is
IPVS/LRSG (the cleavage site is indicated by a slash [15]). Below: the 6His-
tagged YFP-control linker-CFP includes scramble linker. (B) The cDNA of
YFP–MSS–CFP was cloned into the pDisplay® vector, which was fused at the
N-terminus to the murine Ig K-chain leader sequence, which directs the protein
to the secretory pathway, and at the C-terminus to the transmembrane domain of
PDGFR, which anchors the protein in the plasma membrane, displaying it on the
extracellular side. (C) Schematic representation of YFP–MSS–CFPdisplay
localization on the cell surface. YFP–MSS–CFPdisplay is expressed and
anchored on the cell membrane, where the FRET signal can be tested and
active MMP can cleave the MSS sequence in YFP–MSS–CFPdisplay. After
cleavage, the FRET and fluorescent signal of YFP will disappear.
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profound impact on a variety of clinical and experimental
studies. In order to test the effects of MMP inhibitors effectively
in real time, MMP2, MMP9, MMP7, and MT1-MMP activities
have been monitored in vitro with another fluorescence-
quenched substrate, Mca–Pro–Leu–Gly–Leu–Dap(Dnp)–
Ala–Arg–NH2, at excitation and emission wavelengths of 328
and 393 nm, respectively [7]. However, the production of these
probes requires complicated and costly synthetic chemical
technology.
Previous studies have demonstrated that it is possible to
sandwich responsive proteins between two fluorescent
proteins (FPs), capable of fluorescence resonance energy
transfer (FRET), and to use these proteins, as indicators,
monitoring Ca2+ [10], cAMP [11] fluctuations and PKA
activity [12], as well as protease activity [13,14] in live cells.
However, it has not been reported that MMP activity has been
monitored using this FP-FRET (Fluorescence Protein-FRET)
method.
In this paper, we designed a genetically encoded
fluorescence indicator for MMPs. It encodes a yellow
fluorescence protein (YFP) and a cyan fluorescence protein
(CFP) linked by a 12-amino-acid-peptide LEGGIPVSLRPV
with a MMP Substrate Site (MSS). Transfer of energy from
CFP to YFP occurs because the emission spectrum of CFP
overlaps significantly with the excitation spectrum of YFP.
This results in YFP emission by energy transfer from CFP
following CFP emission. When MMP cleave MSS site
between CFP and YFP, transfer of energy from excited CFP
to YFP is abolished. In living cells, a surface-anchored YFP–
MSS–CFPdisplay sensor can be used to detect secreted-MMP
activity of the cancer cells. Consequently, this technology can
be applied to screen MMP inhibitors as medicines for cancer
therapy.
2. Methods
2.1. Construction of plasmids
To test MMP activity at the cell level, a mammalian expression vector
pDisplay® (Invitrogen) was chosen. The pDisplay® vector was fused in two
places: (1) at the N-terminus to the murine Ig K-chain leader sequence, which
directs the protein to the secretory pathway, and (2) at the C-terminus to the
transmembrane domain of platelet derived growth factor receptor (PDGFR)
which anchors the protein to the plasma membrane. Thus, it can display the
protein under investigation on the extracellular surface. For this study, a 12-
amino-acid-peptide LEGGIPVSLRPV, including the MSS site IPVS/LRPV, was
chosen to link with two fluorescence proteins. The pECFP-N1 and pEYFP-N1
(Clontech Laboratories) were used as the polymerase chain reaction templates.
To express YFP–MSS–CFP in E. coli and cancer cells, the cDNAs of YFP
and CFP coding sequence were amplified by PCR. Forward and reverse primers
of EYFP were 5′-GAAGATCTATGGTGAGCAAGGGCGAGGAGCTGTT-
CAC-3′ (restriction sites are in italics) and 5′-CGCTCGAGCTTGTA-
CAGCTCGTCCATGCCGAGA-3′ respectively. Forward primers of ECFP
were 5′CTCTTAGATCCGGAATGGTGAGCAAGGGCGAGGAGC3′ and 5′-
CCGCTCGAGGGTGGAATTCCCGTGTCTCTTAGATCCGGA-3′ (the part of
the linker including MMP cleavage site codons is underlined) and reverse
primers and 5′-CAACTGCAG CATGCGGGCGGCGGTCACGAACTCCAG-
CAGG-3′ respectively. The YFP PCR products were cloned into pGEM-T
(Promega), and the cloned cDNA of YFP was selected with right inserted
direction; subsequently the cloned cDNA of YFP was confirmed by sequencing.Next, the CFP PCR product was digested with XhoI and PstI, and subcloned at
the XhoI/PstI site of pGEM-T-YFP. Finally, a subclone was digested with BglII
and PstI, and a DNA fragment of about 1500 bp, including DNA of YFP–MSS–
CFP, was cut off. This DNA fragment was inserted into the plasmid pET-28a to
generate pET-28a-YC (Fig. 1A) and pDisplay to generate pDisplay-YC (Fig.
1B). Another plasmid pET-28a-YC control linker to produce YFP-
SRGGGSEVNLDAE (control peptide)-CFP was also constructed to be a
control.
2.2. Expression and purification of recombinant proteins
The vector pET-28a-YC and pET-28a-YC control linker were transformed
into BL21 (DE3) E. coli (Novagen Corp.) to produce the recombinant 6His-
tagged YFP–MSS–CFP and YFP-control linker-CFP. Bacteria were cultured to
A600=1 and induced with 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG)
for 16 h at 22 °C. For protein purification, cells were disrupted by sonication in
30 ml lysis buffer (20 mM Tris–Cl, pH 7.9, 0.5 M NaCl, 1 mM PMSF) followed
by centrifugation (12,000×g, 40 min). The recombinant protein was further
purified by Ni-NTA resin (Qiagen). A buffer, containing 20 mM Tris–HCl, pH
7.9, 0.5 M NaCl and 60 mM imidazole was used to remove non-specific protein.
For further analysis, the recombinant FRET protein was eluted with a buffer of
Tris–HCl, pH 7.9, 0.5 M NaCl and 250 mM imidazole, and dialyzed in
deionized water. A 12% SDS–PAGE was used to analyze the purity of the
protein. Gels were stained with Coomassie brilliant blue. Protein concentration
was determined by the Folin–Phenol (Lowry) assay.
402 J. Yang et al. / Biochimica et Biophysica Acta 1773 (2007) 400–4072.3. Cell culture and gene transfection
A sample of a human breast tumour cell line MDA-MB 435s was purchased
from the type culture collection of Wuhan University (Wuhan, China). Another
breast tumour cell MCF-7 was kindly provided by Professor Jianfeng Liu
(Huazhong University of Science and Technology, Wuhan). MDA-MB 453s and
MCF-7 cells were routinely cultured in DMEM, supplemented with 10% heat-
inactivated fetal bovine serum (FBS) at 37 °C in 5% CO2.
The plasmid pDisplay-YC was transfected into MDA-MB 435s and MCF-7
cells by So-fast® transfection reagent, according to the instructions of the manu-
facturer (Sunma Biotechnology Corp., Xiamen City, China). After transfection,
cells were selected by exposing them to G418 (Sigma) 800 μg/ml; the stable
cell lines were cloned.
2.4. Fluorescence spectroscopy
The purified recombinant protein YFP–MSS–CFP was incubated with
20 nM MMP2. The reaction mixtures (pH 7.8) were transferred to a 1-cm
cuvette of a spectrofluorometer (LS-50B, Perkin-Elmer, Norwalk, CT) at 37 °C.
Fluorescence emission spectra from 460 to 600 nm were recorded after
excitation at 433 nm (5 nm bandwidth). The FRET efficiencies were calculated
by the fluorescence emission ratio of YFP (528 nm) to CFP (476 nm).
The YFP–MSS–CFPdisplay expressing cells were collected and re-suspended
in PBS. The cell suspensions were then done directly for fluorescence
spectroscopy measurements using a spectrofluorometer. The samples were
measured in a quartz cuvette. The emission spectra of the samples were collected
from 460 to 600 nm (7.5 nm bandwidth), after being excited at 433 nm (5 nm
bandwidth). The same amount of non-transfected cells was used as a
background control.
2.5. Gelatin zymography
To assess the MMP activity in MCF-7 and MDA-MB-435s cells, gelatin
zymography was performed. For the preparation of a conditioned medium for
gelatin zymography, cells (at about 80% confluence) were washed three times
with PBS. Cells were then cultured for an additional 24 h in a serum-free
medium before collecting the conditioned medium for MMP assays. Serum-free,
24-h conditioned media as described above were collected. The collected media
were centrifuged at 12,000×g for 3 min to remove cellular debris; 30 μl of
supernatant medium was mixed with 30 μl of 2× SDS sample buffer without
boiling. 30 μl of mixed samples were then electrophoresed at 4 °C on 10% SDS-
polyacrylamide gel containing 0.1% gelatin. After electrophoresis, the gel was
washed twice for 15 min in 2.5% Triton X-100 at room temperature to remove
SDS. Finally, the gel was incubated for 16 h at 37 °C in 50 mM Tris–HCl buffer,
pH 7.5, containing 200 mM NaCl and 10 mM CaCl2. The gel was fixed and
stained with 0.5% Coomassie blue R250 in a mixture of 30%methanol and 10%
acetic acid for 15 min at room temperature, and destained with the same solution
without Coomassie blue. A proteolytic band appeared clear on a blue-stained
background.
2.6. Fluorescent imaging
We used an Olympus FV1000 confocal microscope (Olympus corp., JP)
operating with an argon laser. The laser was tuned to lines at 458 and 515 nm.
CFP was excited at 458 nm and YFP at 515 nm, Cells were examined with a
60×1.3 NA oil immersion objective and 2× zoom. The value of the ratio of
FRET was calculated by using the equation RFRET=FRET/CFP. The DM 505
beamsplitter directs the CFP emission to photomultiplier 1 (PMT1) and the YFP
emission to photomultiplier 2 (PMT2). Emissions to each PMT were passed
through a filter, specifically a bandpass for CFP emissions (BP470–500–PMT1)
and a bandpass for YFP emissions (BP530–600–PMT2). The digital
fluorescence images were processed using Matlab7.0 software to calculate the
ratio of FRET/CFP.
Fluorescence microscopy IX-70, with a cooled CCD (Princeton) controlled
by computer software Winview32 also was used to detect inhibitor effects of
GM6001 and MMP2 inhibitor I (Calbiochem, Germany) on living cells. The
cells were observed using a set of filters for each channel: the CFP Channel (EX.425–445HQ, DM. 450 nm, EM.460–510HQ, Olympus corp.), the YFP channel
(EX.490–500HQ, DM.505 nm, EM. 515–560HQ, Olympus corp.), and the
FRET channel (EX.D436/20x, DM. 455DCLP, EM.D535/30m, Chroma corp.).
2.7. Analyzing the MMP inhibitor effect
To study the effects of the MMP inhibitor on MMP2 activity, MDA-MB
435s stably expressed pDisplay-YC were seeded into a 12-well plate with the
same cell number. Cells were then treated with 40 μM GM6001 or 10 μM
MMP2 inhibitor MMP2 inhibitor I (Calbiochem, Germany); control cells were
added into PBS. The fluorescence signal of each group of cells was recorded
through the filter cube of CFP, YFP and FRET in an Olympus IX70 inverted
microscope.
2.8. Western blotting
Cells were collected at 800 rpm for 8 min and washed with phosphate-
buffered saline (PBS). The cell pellets were re-suspended in lysis buffer (62.5
mM Tris–HCl, pH 6.8, 10% (v/v) glycerin, 2% (w/v) SDS, 1 mM
phenylmethylsulfonyl fluoride). The extract of cell were immediately incubated
for 10 min at 95 °C. Proteins were separated in the 10% SDS-PAGE, and
subsequently transferred onto a polyvinylidene difluoride membrane (PVDF,
Amersham) with a semi-dry blotting system. Following blotting, the membrane
was probed with an anti-GFP antibody (1:2000) (Clontech) in TBSTwith 0.5%
Tween-20. The immunoblot was then probed with goat anti-rabbit IgG-
horseradish peroxidase-conjugate (1:5000) (Bio-Rad), and the bands were
detected using the ECLWestern blotting analysis system (Amersham).
3. Results
3.1. Characterization of the recombinant FRET sensor in vitro
The cDNA of YFP–MSS–CFP and CFP-control linker-YFP
were inserted into pET-28a (Fig. 1A), which is able to express
the recombinant YFP–MSS–CFP and CFP-control linker-YFP
in E. coli BL21 (DE3) when induced with IPTG. 6His-tagged
YFP–MSS–CFP, CFP-control linker-YFP and MMP2 were
purified through a Ni-NTA column after induction with 1 mM
IPTG.
To prove the ability of the FRET sensor YFP–MSS–CFP to
detect the activity of MMP2, 6His-tagged YFP–MSS–CFP and
MMP2 were mixed; the kinetic effect of MMP2 on YFP–MSS–
CFP was detected using the spectrofluorometer at 37 °C. Fig.
2A shows the emission spectra of purified YFP–MSS–CFP,
recorded with an excitation wavelength of 433 nm. The two
emission peaks of YFP–MSS–CFP occurred at 476 nm and
528 nm, and fluorescence intensity ratio of 528/476 nm was 4.5.
This result indicates that strong FRET from CFP to YFP
occurred. After adding 20 nM MMP2 to the solution of YFP–
MSS–CFP, a significant decrease of emission at the wavelength
of 528 nm was observed during each 2-min scanning interval.
The ratio of 528 to 476 gradually decreased as time elapsed.
Then we also kinetically monitored production of cleaved
products by SDS-PAGE (as showed in Fig. 2B). The result
showed that YFP–MSS–CFP was gradually cleaved by MMP2.
Meantime, two approximate 31 kDa bands (CFP and YFP) were
accumulated and became dominant after proteolytic reaction.
In order to confirm further the ability of the purified sensor
to measure MMP activity, a broad–spectrum MMP inhibitor,
1,10-phenathroline, a zinc chelator [22], was used to inhibit
the effects of MMP2 on YFP–MSS–CFP. Fig. 2C shows the
Fig. 2. Characterization of the recombinant FRET sensor in vitro. (A) 6His-tagged YFP–MSS–CFP was incubated with MMP2 (concentrations 20 nM) at 37 °C.
Fluorescence emission spectra were recorded after excitation at 433 nm. (B) 6His-tagged YFP–MSS–CFP in a buffer (10 mM pH 8.0 Tris–HCl, 5 mM CaCl2 and
1 μMZnCl2) and 20 nMMMP2 was added and digestion took place at 37 °C. At times indicated in the figure, aliquots of the reaction mixture were removed, quenched
by boiled in water, and analyzed by 12% PAGE gel. (C) Purified YFP–MSS–CFP was used to detect inhibition by different concentrations of 1,10-phenathroline
(0 μM, 250 μM, 500 μM and 1 mM). 20 nM MMP2 was incubated with 3.5 μM YFP–MSS–CFP and different concentrations of 1,10-phenathroline. The relative
fluorescence ratio (528/476 nm) was plotted at each time. (D) SDS-PAGE electrophoresis demonstrates the cleavage of YFP–MSS–CFP. The samples were purified
6His-tagged YFP–MSS–CFP after incubation for 40 min with mature MMP2 in the presence (+) (lane 1) and absence (−) (lane 3) of 1 mM 1,10-phenathroline at
37 °C. The products of YFP-scramble linker-CFP incubated with MMP2 are shown in lane 2. (E) MMP2, MMP3, MMP8, MMP9 with equal activity unit were
individually incubated with 10 μM YFP–MSS–CFP for 1 h. Then the products were run in 12% SDS-PAGE gel after boiled.
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CFP in the solution of YFP–MSS–CFP and 20 nM MMP2
pre-incubated with 250 μM, 500 μM, and 1 mM 1,10-
phenathroline, respectively. When 1,10-phenathroline was
absent, the emission ratio of 528/476 nm dramatically
decreased. However, the emission ratio of 528/476 nm
decreased only slightly when we used a high concentration
of 1,10-phenathroline (1 mM) to inhibit the MMP2 activity.
These results confirm that the FRET sensor YFP–MSS–CFP
is a valid measuring device, sensitive enough to monitor
MMP2 activity in vitro, and able to rapidly and conveniently
evaluate and screen MMP inhibitors.
Subsequently, we also analyzed it using SDS-PAGE. Fig.
2D shows that YFP–MSS–CFP remained intact when YFP–
MSS–CFP was incubated with MMP2 in the presence of
1 mM 1,10-phenathroline (lane 1). The YFP-control peptide-CFP was not either cleaved by MMP2 (lane 2). However,
when YFP–MSS–CFP was incubated with MMP2 in the
absence of 1,10-phenathroline (lane 3), it was cleaved. This
result verifies that MMP2 cleaved YFP–MSS–CFP into YFP
and CFP, and that 1,10-phenathroline could inhibit MMP2
activity.
Next, we examined the sensitivity of YFP–MSS–CFP for
MMPs in vitro. MMPs have been reported to exhibit some
overlap in substrate specificity [15]. IPVS-LRSG peptide is
cleaved at greatest rate by MMP-2 [15]. We incubated the YFP–
MSS–CFP against a panel of MMP: MMP-2, MMP-3, MMP-8,
and MMP-9. Fig. 2D showed MMP3, MMP8, and MMP9 have
a part of activity for YFP–MSS–CFP when compared with
MMP2. Human β-secretase (β-site APP-cleaving enzyme,
Sigma) was added to the control experiment with no cleavage
products observed (data not shown).
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MMP are secreted as the proenzyme and can completely
degrade the extracellular matrix components once activated
[16]. To test MMP at the cell level, we chose a vector
pDisplay®, a mammalian expression vector. In the experi-
ments, the pDisplay carried a murine Ig κ-chain leader
sequence at the N-terminus, directing the protein to the
secretory pathway, and a transmembrane domain of PDGFR
at the C-terminus, which anchors the protein to the plasma
membrane. Consequently, cDNA of YFP–MSS–CFP
sequences were inserted into pDisplay to produce pDisplay-
YC (Fig. 1B). pDisplay-YC expresses YFP–MSS–CFPdisplay
in the cancer cells that can be anchored on the cellular
surface, where fluorescence sensors can be cleaved by
secreted MMP (Fig. 1C). After cleavage, YFP was cut off
and moved away from the cellular surface, while CFP
remained anchored on the surface of the plasma membrane.
Therefore, decreased FRET efficiency or YFP fluorescent
signal in YFP–MSS–CFPdisplay expressing cells could reflect
the activity of MMP.
MCF-7 cells were transfected with pDisplay-CFP, pDisplay-
YFP and pDisplay-YC (Fig. 3). The confocal sections of
imaging show that the fluorescence proteins surround the cell.
Emission from CFP was detected as strong fluorescence in the
CFP channel (470–500 nm, excited at 458 nm), no bleed-
through fluorescence in the YFP channel (530–600 nm, excited
at 515 nm) and a little bleed-through in FRET channel (530–
600 nm, excited at 458 nm). Meanwhile, YFP was detected as
strong fluorescence in the YFP channel and no bleed-through
into the CFP channel and only a little into the FRET channel.
YFP–MSS–CFPdisplay was detected as strong fluorescence in
all channels.Fig. 3. Confocal imaging of MCF-7 transfected with pDisplay-CFP (top row), pDisp
were recorded in CFP channel (470–500 nm, excited at 458 nm), FRETchannel (530–
respectively. Confocal imaging shows that the fluorescence proteins surround the ce3.3. Testing different cell lines for MMP expression
MMP are constitutive expression proteins in many different
cancer cell lines. For this study, we chose two kinds of cell lines,
MDA-MB 435s and MCF-7 cells. Zymography was employed
to analyze metalloproteinases in conditioned supernatants of
MDA-MB 435s and MCF-7 cells. Fig. 4A shows that the MDA-
MB 435s breast cancer cell line produced MMP with 72 kDa
and 92 kDa; these results are consistent with the characteristics
of latent MMP2 and MMP9. However, these two molecules
couldn't be detected in MCF-7 cell line. Consequently, we used
MCF-7 cells as a control to analyze MMP activity.
Fig. 4B displays the emission spectra of YFP–MSS–
CFPdisplay expressing MDA-MB 435s and MCF-7 cells excited
at 433 nm. YFP–MSS–CFPdisplay expressingMCF-7 cells peaks
at 528 nm, but YFP–MSS–CFPdisplay expressing MDA-MB
435s cells does not peak at this wavelength. Single cell
fluorescence images of MDA-MB-435s and MCF-7 cells were
acquired through a three-filter method. YFP–MSS–CFPdisplay
expressing MDA-MB 435s cells showed much lower fluores-
cence intensity in the YFP channel than YFP–MSS–CFPdisplay
expressing MCF-7 cells (data not shown). The reason for this
phenomenon is that the MDA-MB-435s cells secrete MMP into
the conditioned medium. Consequently, YFP is cut off and
diffuses into the conditioned medium, resulting in the FRET's
disappearance.
3.4. Real-time FRET detecting MMP2 activity
In the next set of experiments, we investigated the FRET
ratio of FRET sensor YFP–MSS–CFPdisplay at the single cell
level. MCF-7 cells transfected with pDisplay-YC were exposed
to 0.2 μMMMP2 in a conditioned medium, and CFP and FRETlay-YFP (bottom row) and pDisplay-YC (bottom row). The fluorescent signals
600 nm, excited at 458 nm), and YFP channel (530–600 nm, excited at 515 nm),
ll. Scale bar=10 μm.
Fig. 5. Time-course FRET analysis of MMP2 activity. (A) Confocal imaging of
YFP–MSS–CFPdisplay expressing MCF-7 cells are shown in CFP (470–500 nm)
and FRET (530–600 nm) channels and bright field. (Scale bar=10 μm) (B)
Pseudocolor imaging of FRET/CFP emission ratio at different time after the
0.2 μM recombinant MMP2 added into YFP–MSS–CFPdisplay expressingMCF-
7 cells. Real-time fluorescent images were monitored and the images of the
FRET/CFP ratio were calculated with MATLAB 7.0. The color bar in the right
panel represents the value of the ratios. (C) Western blotting shows the cleavage
of YFP–MSS–CFPdisplay by MMP2 in MCF-7 cells. The extract of cells was
subjected to 10% SDS-PAGE and western blotting with an anti-GFP antibody.
The upper blot indicates YFP–MSS–CFPdisplay and the lower blot indicates
CFP. Lane 1, control (MMP2 absent); Lane 2, the cells were incubated with
MMP2. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
Fig. 4. Detecting MMP activity in MDA-MB 435s and MCF-7 cells. (A) To
detect the MMP activity in the cancer cells by gelatin zymography, the equal
amounts of conditioned medium of MDA-MB 435s and MCF-7 cells were
analyzed. Cells were washed three times with PBS. Cells were then cultured for
24 h in a serum-free medium before collecting the conditioned medium for
MMP assays. The collected media were centrifuged at 12,000×g for 3 min to
remove cellular debris and 30 μl of the supernatant was mixed with 30 μl of 2×
SDS sample buffer without boiling. 30 μl of mixed samples were then
electrophoresed at 4 °C on 10% SDS-polyacrylamide gel containing 0.1%
gelatin. After electrophoresis, the gels were washed twice for 15 min in 2.5%
Triton X-100 at room temperature to remove SDS. Finally, the gel was incubated
for 16 h at 37 °C in 50 mM Tris–HCl buffer, pH 7.5, containing 200 mM NaCl
and 10 mM CaCl2. The gel was fixed and stained with Coomassie blue R250,
and destained with the same solution without Coomassie blue. A proteolytic
band appeared clear on a blue-stained background. (B) YFP–MSS–CFPdisplay
expressing MDA-MB 435s and MCF-7 cells were excited at 433 nm and
emission spectra were recorded and normalized.
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(Fig. 5A). In Fig. 5B, pseudo-color images demonstrate that the
emission ratio, FRET/CFP, decreased at the MCF-7 cell surface
after treated with MMP2. To validate the results of the real-time
FRET ratio, Fig. 5C shows that YFP–MSS–CFPdisplay was
digested by MMP2 to produce a small CFP molecule (lane 2),
but the sensor remained intact in the absence of MMP2 (lane 1).
3.5. Using YFP fluorescence to analyze MMP inhibitors effect
To study the effect of MMP inhibitors on MMP activity, the
MDA-MB 435s cell line was chosen because it expresses high
MMP level (Fig. 4A). GM6001 is a potent general MMP
inhibitor [20], and MMP2 inhibitor I is a MMP2-specific
inhibitor [21,23]. YFP–MSS–CFPdisplay expressing MDA-MB-
435s cells were treated with 40 μM GM6001 or 10 μM MMP2
inhibitor I, respectively. Control cells were not treated using
MMP inhibitors. Fig. 6 shows that MMP2 inhibitor I (F3 in Fig.
6A) and GM6001 (I3 in Fig. 6A) significantly increased YFP
fluorescence intensity following 72 h of treatment (Fig. 6C), in
contrast to the controls (C3 in Fig. 6). The reason for this is that
secreted MMP cuts off surface-displayed YFP, and YFP
diffuses into the conditioned medium.
4. Discussion
In this study, we constructed a genetically encoded surface-
displayed FRET sensor that was successfully used to monitor
MMP cleavage activity and to analyze MMP inhibitor effects
both in vitro and in living cells. Although zymography can beemployed to analyze MMP2 and MMP9 activity, in this study,
genetically encoded surface-displayed FRET sensor combined
with FRET imaging technique showed more flexibility and
reliability in monitoring MMP activity in vitro and in living
cells. It should be noted that these recombinant FP-FRET sensor
were anchored on the extracellular surface of the plasma
membrane, as in a previous study where a FRET sensor was
used to detect extracellular glutamate concentration [17].
Moreover, it found that the detection of YFP fluorescence
intensity alone could indicate MMP activity too.
The use of FP-FRET to visualize cellular MMP expression
levels has many advantages over the use of other widely used
fluorescent dyes. Firstly, the FP-FRET sensor can specifically
target cell organelles and cellular microenvironments [18].
Secondly, the genetically encoded FP-FRET sensors are more
easily obtained and cheaper than the synthetic dyes. Thirdly, the
FP-FRET method is more practical for screening novel anti-
Fig. 6. Using YFP fluorescence to analyze the effects of MMP inhibitors. (A)YFP–MSS–CFPdisplay stably expressingMDA-MB 435s were treated with 10 μMMMP2
inhibitor I (D–F) and 40 μMGM6001 (G–I) and control (A–C). Cell fluorescence was detected every 24 h (24 h, top row; 48 h, middle row; 72 h, bottom row) with the
3-channel method. CFP, YFP, and FRET signals were recorded. MMP2 inhibitor I (E3, F3) and GM6001 (H3, I3) significantly increased YFP fluorescence intensity
following 24–72 h of treatment, in contrast to the controls (B3, C3). (B) Ratio analysis of FRET/CFP when using MMP2 inhibitor I and GM6001 and no inhibitor
(Control) to treat MDA-MB 435s cells. Data are mean±SEM for one representative experiment in twelve cells. (C) Analysis of YFP intensity after 72 h of inhibitor
treatment and control. Data are mean SEM for one representative experiment in twelve cells. (D) Western blotting analysis of the sensor using MMP inhibitors 72 h
treatment as described in panel A.
406 J. Yang et al. / Biochimica et Biophysica Acta 1773 (2007) 400–407MMP drugs. The assay can be performed in a convenient 96-
well microplate format using purified enzymes and can be
developed for high-throughput systems. This assay is useful to
screen drug targets or inhibitors of MMP-2, a potential
therapeutic target. Consequently, we designed a genetically
encoded FP-FRET sensor that could be used to detect MMP
activity and applied it to evaluate the effects of MMP inhibitors
in living cells.
During molecular sensor detection in vitro, the emission ratio
(528/476 nm) of FRET sensor showed a 4.3 fold decrease when
the FRETsensor cleaved byMMP2. A large change of the FRET
ratio evidenced that YFP–MSS–CFP can be used to sensitively
detect MMP2 activity. Furthermore, this method can monitor
effects of MMP inhibitors in real time. Accurate information on
biological digestion processes can be made visible. In vitro, we
chose 1,10-phenathroline to inhibit the MMP2, but it was not
chosen for living cells because of its cytotoxicity.
The above results indicate that MMP enzyme activity can be
recorded through the use of fluorescent protein FRET sensor.Two cell lines, MCF-7 with low level of secreted MMP, and
MDA-MB 435s with high MMP expression, were stably
transfected with pDisplay-YC in order to monitor the FRET
signal. The FRET signal in MDA-MB 435s was dramatically
weaker than in the MCF-7 cell. Real-time FRET was also
analyzed with YFP–MSS–CFPdisplay expressing MCF-7 cells
after adding purified MMP2 to the cells. Finally, analysis of the
YFP channel in a single cell showed that the two MMP
inhibitors, GM6001 and MMP2 inhibitor I, could both inhibit
MMP2 activity.
In previous studies, most FRET reactions were within the
cell, not at the cell surface. However, when the FRET sensor
was expressed within the cell, the quantity of FRET acceptor
molecules would not change when FRET sensors were cleaved
because intact cell organelles sealed off all of the molecules. In
contrast, when the FRET sensor was expressed on the cell
surface to detect MMP, the quantity of FRET acceptor
molecules would decrease since they diffuse away from the
cell membrane. Therefore, besides FRET ratio analysis of MMP
407J. Yang et al. / Biochimica et Biophysica Acta 1773 (2007) 400–407activity, an acceptor signal can also be used to analyze MMP
activity.
Fluorescence detection of proteinase activity has two
important applications—the analysis of the biological functions
of proteinases and the screening of specific inhibitor drugs.
Highly sensitive and specific synthetic fluorogenic substrates
have been used for high-throughput screening of small-
molecule inhibitors. Future studies involving fluorescence
assays of MMP inhibitors in live tissue will provide a platform
for high-throughput screening of MMP inhibitors.
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